Logo image of AAMC

ALTISOURCE ASSET MANAGEMENT (AAMC) Stock Analyst Earnings Estimates

NYSEARCA:AAMC - NYSE Arca - VI02153X1080 - Common Stock - Currency: USD

1.25  -0.06 (-4.59%)

After market: 1.28 +0.03 (+2.4%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
AAMC revenue by date.AAMC revenue by date.
5M-11.69M
-333.80%
EBITDA
YoY % growth
AAMC ebitda by date.AAMC ebitda by date.
-9.49M
31.97%
-7.3M
23.08%
-26.869M
-268.07%
EBIT
YoY % growth
AAMC ebit by date.AAMC ebit by date.
-9.8M
31.47%
-7.5M
23.47%
-27.116M
-261.55%
Operating Margin
AAMC operating margin by date.AAMC operating margin by date.
N/A-150.00%231.96%
EPS
YoY % growth
AAMC eps by date.AAMC eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
AAMC Yearly EPS VS EstimatesAAMC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth
234K
-87.68%
%
Q4 2023
Q2Q % growth
-7.411M
-396.44%
%
Q3 2023
Q2Q % growth
-8.1M
-526.32%
%
Q2 2023
Q2Q % growth
1.92M
284.00%
%
Q2 2020
Q2Q % growth

100.00%
%
Q1 2020
Q2Q % growth

-100.00%
%
AAMC Yearly Revenue VS EstimatesAAMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A